Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Increasing mortality of intrahepatic cholangiocarcinoma in the US: are gender-specific risk factors important?

Antwi SO, Patel T.

Hepatobiliary Surg Nutr. 2019 Dec;8(6):635-636. doi: 10.21037/hbsn.2019.10.10. No abstract available.

2.

Genome-wide discovery and validation of diagnostic DNA methylation-based biomarkers for hepatocellular cancer detection in circulating cell free DNA.

Hlady RA, Zhao X, Pan X, Yang JD, Ahmed F, Antwi SO, Giama NH, Patel T, Roberts LR, Liu C, Robertson KD.

Theranostics. 2019 Sep 25;9(24):7239-7250. doi: 10.7150/thno.35573. eCollection 2019.

3.

Risk of De Novo Hepatocellular Carcinoma Following Use of Direct Acting Antiviral Medications for Treatment of Chronic Hepatitis C.

Antwi SO, Van Houten HK, Sangaralingham LR, Patel T.

Cancer Prev Res (Phila). 2019 Dec;12(12):891-902. doi: 10.1158/1940-6207.CAPR-19-0162. Epub 2019 Aug 26.

PMID:
31451519
4.

A SEER-based multi-ethnic picture of advanced intrahepatic cholangiocarcinoma in the United States pre- and post-the advent of gemcitabine/cisplatin.

Mody K, Antwi SO, Hodge DO, Ailawadhi S, Roberts L, Bekaii-Saab T.

J Gastrointest Oncol. 2018 Dec;9(6):1063-1073. doi: 10.21037/jgo.2018.07.09.

5.

Response to Loco-Regional Therapy Predicts Outcomes After Liver Transplantation for Combined Hepatocellular-Cholangiocarcinoma.

Antwi SO, Habboush YY, Chase LA, Lee DD, Patel T.

Ann Hepatol. 2018 Oct 16;17(6):969-979. doi: 10.5604/01.3001.0012.7197.

6.

CDKN2A Germline Rare Coding Variants and Risk of Pancreatic Cancer in Minority Populations.

McWilliams RR, Wieben ED, Chaffee KG, Antwi SO, Raskin L, Olopade OI, Li D, Highsmith WE Jr, Colon-Otero G, Khanna LG, Permuth JB, Olson JE, Frucht H, Genkinger J, Zheng W, Blot WJ, Wu L, Almada LL, Fernandez-Zapico ME, Sicotte H, Pedersen KS, Petersen GM.

Cancer Epidemiol Biomarkers Prev. 2018 Nov;27(11):1364-1370. doi: 10.1158/1055-9965.EPI-17-1065. Epub 2018 Jul 23.

7.

Risk of Different Cancers Among First-degree Relatives of Pancreatic Cancer Patients: Influence of Probands' Susceptibility Gene Mutation Status.

Antwi SO, Fagan SE, Chaffee KG, Bamlet WR, Hu C, Polley EC, Hart SN, Shimelis H, Lilyquist J, Gnanaolivu RD, McWilliams RR, Oberg AL, Couch FJ, Petersen GM.

J Natl Cancer Inst. 2019 Mar 1;111(3):264-271. doi: 10.1093/jnci/djx272.

8.

Association Between Inherited Germline Mutations in Cancer Predisposition Genes and Risk of Pancreatic Cancer.

Hu C, Hart SN, Polley EC, Gnanaolivu R, Shimelis H, Lee KY, Lilyquist J, Na J, Moore R, Antwi SO, Bamlet WR, Chaffee KG, DiCarlo J, Wu Z, Samara R, Kasi PM, McWilliams RR, Petersen GM, Couch FJ.

JAMA. 2018 Jun 19;319(23):2401-2409. doi: 10.1001/jama.2018.6228.

9.

Racial, Ethnic, and Age Disparities in Incidence and Survival of Intrahepatic Cholangiocarcinoma in the United States; 1995-2014.

Antwi SO, Mousa OY, Patel T.

Ann Hepatol. 2018 July - August ,;17(4):604-614. doi: 10.5604/01.3001.0012.0929.

10.

Pancreatic cancer risk is modulated by inflammatory potential of diet and ABO genotype: a consortia-based evaluation and replication study.

Antwi SO, Bamlet WR, Pedersen KS, Chaffee KG, Risch HA, Shivappa N, Steck SE, Anderson KE, Bracci PM, Polesel J, Serraino D, La Vecchia C, Bosetti C, Li D, Oberg AL, Arslan AA, Albanes D, Duell EJ, Huybrechts I, Amundadottir LT, Hoover R, Mannisto S, Chanock SJ, Zheng W, Shu XO, Stepien M, Canzian F, Bueno-de-Mesquita B, Quirós JR, Zeleniuch-Jacquotte A, Bruinsma F, Milne RL, Giles GG, Hébert JR, Stolzenberg-Solomon RZ, Petersen GM.

Carcinogenesis. 2018 Jul 30;39(8):1056-1067. doi: 10.1093/carcin/bgy072.

11.

Racial, Ethnic, and Age Disparities in Incidence and Survival of Intrahepatic Cholangiocarcinoma in the United States; 1995-2014.

Antwi SO, Mousa OY, Patel T.

Ann Hepatol. 2018 Mar 1;17(2):274-285. doi: 10.5604/01.3001.0010.8663.

12.

Leukocyte Telomere Length and Pancreatic Cancer Risk: Updated Epidemiologic Review.

Antwi SO, Petersen GM.

Pancreas. 2018 Mar;47(3):265-271. doi: 10.1097/MPA.0000000000000995. Review.

13.

Inflammatory potential of diet and risk of pancreatic cancer in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.

Zheng J, Merchant AT, Wirth MD, Zhang J, Antwi SO, Shoaibi A, Shivappa N, Stolzenberg-Solomon RZ, Hebert JR, Steck SE.

Int J Cancer. 2018 Jun 15;142(12):2461-2470. doi: 10.1002/ijc.31271. Epub 2018 Feb 2.

14.

Alcohol consumption, variability in alcohol dehydrogenase genes and risk of renal cell carcinoma.

Antwi SO, Eckel-Passow JE, Diehl ND, Serie DJ, Custer KM, Wu KJ, Cheville JC, Thiel DD, Leibovich BC, Parker AS.

Int J Cancer. 2018 Feb 15;142(4):747-756. doi: 10.1002/ijc.31103. Epub 2017 Oct 28. Erratum in: Int J Cancer. 2018 Sep 1;143(5):E6.

15.

Coffee consumption and risk of renal cell carcinoma.

Antwi SO, Eckel-Passow JE, Diehl ND, Serie DJ, Custer KM, Arnold ML, Wu KJ, Cheville JC, Thiel DD, Leibovich BC, Parker AS.

Cancer Causes Control. 2017 Aug;28(8):857-866. doi: 10.1007/s10552-017-0913-z. Epub 2017 Jun 24.

16.

Telomere Length and Pancreatic Cancer Risk-Reply.

Antwi SO, Boardman LA, Petersen GM.

Cancer Epidemiol Biomarkers Prev. 2017 Jul;26(7):1158-1159. doi: 10.1158/1055-9965.EPI-17-0307. Epub 2017 Jun 20. No abstract available.

17.

Genetically Predicted Telomere Length is not Associated with Pancreatic Cancer Risk.

Antwi SO, Bamlet WR, Broderick BT, Chaffee KG, Oberg A, Jatoi A, Boardman LA, Petersen GM.

Cancer Epidemiol Biomarkers Prev. 2017 Jun;26(6):971-974. doi: 10.1158/1055-9965.EPI-17-0100. Epub 2017 Mar 6.

18.

Carotenoid intake and adipose tissue carotenoid levels in relation to prostate cancer aggressiveness among African-American and European-American men in the North Carolina-Louisiana prostate cancer project (PCaP).

Antwi SO, Steck SE, Su LJ, Hebert JR, Zhang H, Craft NE, Fontham ET, Smith GJ, Bensen JT, Mohler JL, Arab L.

Prostate. 2016 Sep;76(12):1053-66. doi: 10.1002/pros.23189. Epub 2016 Jun 8.

19.

Pancreatic cancer: associations of inflammatory potential of diet, cigarette smoking and long-standing diabetes.

Antwi SO, Oberg AL, Shivappa N, Bamlet WR, Chaffee KG, Steck SE, Hébert JR, Petersen GM.

Carcinogenesis. 2016 May;37(5):481-90. doi: 10.1093/carcin/bgw022. Epub 2016 Feb 12.

20.

Exposure to environmental chemicals and heavy metals, and risk of pancreatic cancer.

Antwi SO, Eckert EC, Sabaque CV, Leof ER, Hawthorne KM, Bamlet WR, Chaffee KG, Oberg AL, Petersen GM.

Cancer Causes Control. 2015 Nov;26(11):1583-91. doi: 10.1007/s10552-015-0652-y. Epub 2015 Aug 21.

21.

Plasma carotenoids and tocopherols in relation to prostate-specific antigen (PSA) levels among men with biochemical recurrence of prostate cancer.

Antwi SO, Steck SE, Zhang H, Stumm L, Zhang J, Hurley TG, Hebert JR.

Cancer Epidemiol. 2015 Oct;39(5):752-62. doi: 10.1016/j.canep.2015.06.008. Epub 2015 Jul 9.

22.

Dietary, supplement, and adipose tissue tocopherol levels in relation to prostate cancer aggressiveness among African and European Americans: The North Carolina-Louisiana Prostate Cancer Project (PCaP).

Antwi SO, Steck SE, Su LJ, Hébert JR, Zhang H, Fontham ET, Smith GJ, Bensen JT, Mohler JL, Arab L.

Prostate. 2015 Sep;75(13):1419-35. doi: 10.1002/pros.23025. Epub 2015 Jun 5.

Supplemental Content

Loading ...
Support Center